Automated Insulin Delivery Reduces Overnight Diabetes Management by Caregivers While Improving Nocturnal Glycemic Control in Young Children With Type 1 Diabetes - Summary - MDSpire
To assess hourly patterns of insulin delivery and glucose profiles in children using an automated insulin delivery system.
Approach:
Statistical Analysis: Statistical analyses were performed using Python, with comparisons made using Wilcoxon signed-rank tests and Spearman’s rank correlation, with a significance level set at p < 0.05.
Key Findings:
Total daily insulin dose increased from 13.3 to 16.2 IU/day (p < 0.001).
During the dusk period (20:00–24:00), user-initiated correction boluses decreased significantly, while automatically delivered insulin increased.
From 00:00 to 05:00, total and basal insulin delivery increased, leading to lower and more stable nighttime sensor glucose levels.
Automated insulin delivery significantly increased time in range (TIR) from 60.6% to 78.3% (p < 0.001) and time in tight range (TITR) from 38.5% to 52.5% (p < 0.001) overnight.
Interpretation:
Automated insulin delivery reduced the need for active parental intervention overnight, resulting in greater sensor glucose stability and reduced glucose variability.
Limitations:
Limited generalizability due to the small sample size of 31 participants.
The study focused on a specific age group (2-6 years), which may not represent older children or adolescents.
Conclusion:
Automated insulin delivery systems may alleviate caregiver burden and improve glycemic control during nighttime in young children with type 1 diabetes.
A large BRFSS analysis points to persistent screening disparities among sexual orientation and gender identity minority respondents, with particularly large gaps in some gender identity minority groups.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
